Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 342-394
Closed Access | Times Cited: 140
Design, Synthesis and Evaluation of Quinazoline-Chalcone Hybrids as Inducers of Cell-Cycle Arrest and Apoptosis in Breast Cancer via DNA Damage and CDK2/ATR Inhibition
Giulia Rodrigues Stringhetta, Eduardo Bustos Mass, Izabela Natália Faria Gomes, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100250-100250
Open Access
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39
Design, multistep synthesis and in-vitro antimicrobial and antioxidant screening of coumarin clubbed chalcone hybrids through molecular hybridization approach
Sathish Kumar Konidala, Vijay Kotra, Ravi Chandra Sekhara Reddy Danduga, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 6, pp. 103154-103154
Open Access | Times Cited: 35
1,2,3-Triazole Derivatives with Anti-breast Cancer Potential
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 22
A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity
Konrad Kowalski
Coordination Chemistry Reviews (2022) Vol. 479, pp. 214996-214996
Closed Access | Times Cited: 19
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Ferrocenyl Azoles: Versatile N‐Containing Heterocycles and their Anticancer Activities
Bhavya Deepthi Sadanala, Rajiv Trivedi
The Chemical Record (2024) Vol. 24, Iss. 7
Closed Access | Times Cited: 2
Phytochemistry reflects different evolutionary history in traditional classes versus specialized structural motifs
Kathryn A. Uckele, Joshua P. Jahner, Eric J. Tepe, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells
Gábor Girst, Elizabeth A. Lopes, Lídia Gonçalves, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1778-1786
Open Access | Times Cited: 7
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
József Murányi, Cintia Duró, Bianka Gurbi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3456-3456
Open Access | Times Cited: 3
Thymoquinone-protoflavone hybrid molecules as potential antitumor agents
Sara Hassan Hassan Ahmed, Bizhar Ahmed Tayeb, Tímea Gonda, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0291567-e0291567
Open Access
Synthetic and DFT Modeling Studies on Suzuki–Miyaura Reactions of 4,5-Dibromo-2-methylpyridazin-3(2H)-one with Ferrocene Boronates, Accompanied by Hydrodebromination and a Novel Bridge-Forming Annulation In Vitro Cytotoxic Activity of the Ferrocenyl–Pyridazinone Products
Nour-Eddine El Alaoui, Mohammed Boulhaoua, Dániel Hutai, et al.
Catalysts (2022) Vol. 12, Iss. 6, pp. 578-578
Open Access | Times Cited: 2
Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents
Sara Hassan Hassan Ahmed, Bizhar Ahmed Tayeb, Tímea Gonda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Protoflavone – spirooxindole hybrids exhibit promising, increased antitumor activity
Gábor Girst, ElizabethA Lopes, Margarida Espadinha, et al.
Planta Medica (2021) Vol. 87
Closed Access
Page 1

Scroll to top